Psilocybin Shows No Lasting Behavioral Effect in Mice
A five-lab study found psilocybin produced no lasting behavioral changes in mice 24 hours after a single dose.
Updated on Nov. 2, 2026 in Mental Health
Researchers from UC Berkeley, UCSF and Stanford ran identical parallel experiments across five laboratories and published the results in Nature Neuroscience. The study found no reproducible reduction in anxiety or depression-like behaviors, though mice showed short-term changes ten minutes after dosing.
Why it matters
The findings challenge claims of durable behavioral benefits from a single psilocybin dose in animal models. Researchers say consistently reproducible immediate responses offer a starting point for studying how the compound affects neuronal circuits.
The study compared five laboratories running identical experiments and found no lasting effects at 24 hours after dosing, while immediate changes appeared at 10 minutes. Only two of the five laboratories observed significant effects in one of two depression assays, and it remains unclear why results were inconsistent across assays.
The players
University of California, Berkeley
A public research university whose researchers led the multi-laboratory psilocybin study published in Nature Neuroscience.
University of California, San Francisco
A public research university in San Francisco whose researchers took part in the five-laboratory psilocybin experiments.
Stanford University
A private research university in California whose researchers participated in the multi-laboratory psilocybin study.
The details
Five labs combined their data after running the same experiments in parallel on psilocybin's behavioral effects in mice. Mice displayed increased anxiety and avoidance, and reduced fear expression, ten minutes after dosing, but researchers found no evidence that the drug reopened a critical period for social reward learning in adult mice.
Timeline
Ten minutes after dosing: mice showed short-term anxiety and reduced fear responses.
24 hours after a single dose: no lasting behavioral changes were measured.
November 2, 2026: the findings were published in Nature Neuroscience.
Health Landscape
The study adds to replication-focused psychopharmacology research that tests whether early psilocybin findings hold across independent laboratories. Its emphasis on publishing negative results alongside positive ones reflects a push for more reliable evidence before clinical use.
Readers should not expect this animal study to change treatment options or access today. The findings show that effects seen shortly after dosing did not persist, which matters for anyone following psilocybin research for mental health.
The takeaway
Single-dose effects reported in early research may not last, so evidence from multiple independent labs is worth weighing before drawing conclusions about psilocybin.
Further reading
Explore more research on Mental Health developments and how psychedelic compounds are being studied.
Source note: This article includes information reported by Drug Target Review.
